McKesson (MCK) Stock Buyback History
TTM buyback yield 4.27% · Shareholder yield (TTM) 4.27%.
MCK
TTM buyback yield
4.27%
Shareholder yield (TTM)
4.27%
5Y share count change
-22.7%
TTM buyback spend
$4.51B
SBC coverage (TTM)
N/A
YoY change in spend
+51.0%
5Y CAGR of spend
+45.0%
Peak year (2026)
$4.75B
Cumulative spend
$38.74B
TTM metrics calculated from the four most recent reported quarters, ending (reported ).
Key takeaways
- McKesson (MCK) repurchased about $4.51B of stock over the trailing twelve months.
- Diluted share count is down 22.7% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- Cash buyback spend has compounded at +45.0% per year over the latest 5-year window.
- TTM repurchases used about 81% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2026 | $4.75B | $0.00 | $4.75B | 0.12B | -3.1% | 4.50% |
| 2025 | $3.15B | $0.00 | $3.15B | 0.13B | -4.5% | 3.73% |
| 2024 | $3.02B | $0.00 | $3.02B | 0.13B | -5.7% | 4.31% |
| 2023 | $3.64B | $162.00M | $3.48B | 0.14B | -7.7% | 7.46% |
| 2022 | $3.52B | $161.00M | $3.35B | 0.15B | -4.0% | 7.80% |
| 2021 | $742.00M | $0.00 | $742.00M | 0.16B | -11.8% | 2.40% |
| 2020 | $1.93B | $0.00 | $1.93B | 0.18B | -7.8% | 8.26% |
| 2019 | $1.64B | $0.00 | $1.64B | 0.20B | -5.6% | 7.22% |
| 2018 | $1.71B | $69.00M | $1.64B | 0.21B | -6.3% | 5.92% |
| 2017 | $2.31B | $115.00M | $2.20B | 0.22B | -4.3% | 7.35% |
| 2016 | $1.61B | $123.00M | $1.49B | 0.23B | -0.9% | 4.52% |
| 2015 | $450.00M | $174.00M | $276.00M | 0.23B | 0.9% | 0.86% |
| 2014 | $130.00M | $160.00M | −$30.00M | 0.23B | -2.5% | 0.32% |
| 2013 | $1.21B | $167.00M | $1.05B | 0.24B | -4.8% | 4.96% |
| 2012 | $1.87B | $154.00M | $1.72B | 0.25B | -4.6% | 9.05% |
| 2011 | $2.05B | $137.00M | $1.91B | 0.26B | -3.7% | 10.41% |
| 2010 | $323.00M | $114.00M | $209.00M | 0.27B | -2.2% | 1.85% |
| 2009 | $502.00M | $99.00M | $403.00M | 0.28B | -6.4% | 5.31% |
| 2008 | $1.70B | $91.00M | $1.61B | 0.30B | -2.3% | 11.71% |
| 2007 | $1.00B | $0.00 | $1.00B | 0.30B | -3.5% | 5.81% |
| 2006 | $958.00M | $0.00 | $958.00M | 0.32B | 7.5% | 6.09% |
| 2005 | $0.00 | $0.00 | $0.00 | 0.29B | -1.7% | — |
| 2004 | $156.80M | $0.00 | $156.80M | 0.30B | 0.1% | 1.80% |
| 2003 | $25.00M | $0.00 | $25.00M | 0.30B | 0.2% | 0.35% |
| 2002 | $44.20M | $0.00 | $44.20M | 0.30B | 5.3% | 0.41% |
| 2001 | $65.60M | $0.00 | $65.60M | 0.28B | -0.4% | 0.87% |
| 2000 | $0.00 | $0.00 | $0.00 | 0.28B | 3.3% | — |
| 1999 | $0.00 | $0.00 | $0.00 | 0.28B | 187.8% | — |
| 1998 | $0.00 | $0.00 | $0.00 | 0.10B | 13.3% | — |
| 1997 | $157.90M | $0.00 | $157.90M | 0.08B | — | — |
| 1996 | $62.70M | $0.00 | $62.70M | — | — | — |
| 1995 | $3.10M | $0.00 | $3.10M | — | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for McKesson (MCK) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for McKesson (MCK)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for McKesson (MCK)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2026 | $4.75B | +51.0% | +$1.60B | ||
| 2025 | $3.15B | +4.0% | +$121.00M | ||
| 2024 | $3.02B | -16.8% | -$613.00M | ||
| 2023 | $3.64B | +3.5% | +$122.00M | ||
| 2022 | $3.52B | +373.9% | +$2.77B | ||
| 2021 | $742.00M | -61.6% | -$1.19B | ||
| 2020 | $1.93B | +18.0% | +$295.00M | ||
| 2019 | $1.64B | -4.1% | -$70.00M | ||
| 2018 | $1.71B | -26.0% | -$602.00M | ||
| 2017 | $2.31B | +43.4% | +$699.00M | ||
| 2016 | $1.61B | +258.2% | +$1.16B | ||
| 2015 | $450.00M | +246.2% | +$320.00M | ||
| 2014 | $130.00M | -89.3% | -$1.08B | ||
| 2013 | $1.21B | -35.2% | -$660.00M | ||
| 2012 | $1.87B | -8.6% | -$176.00M | ||
| 2011 | $2.05B | +534.7% | +$1.73B | ||
| 2010 | $323.00M | -35.7% | -$179.00M | ||
| 2009 | $502.00M | -70.4% | -$1.20B | ||
| 2008 | $1.70B | +69.3% | +$695.00M | ||
| 2007 | $1.00B | +4.7% | +$45.00M | ||
| 2006 | $958.00M | — | +$958.00M | ||
| 2005 | $0 | -100.0% | -$156.80M | ||
| 2004 | $156.80M | +527.2% | +$131.80M | ||
| 2003 | $25.00M | -43.4% | -$19.20M | ||
| 2002 | $44.20M | -32.6% | -$21.40M | ||
| 2001 | $65.60M | — | +$65.60M | ||
| 2000 | $0 | — | $0 | ||
| 1999 | $0 | — | $0 | ||
| 1998 | $0 | -100.0% | -$157.90M | ||
| 1997 | $157.90M | +151.8% | +$95.20M | ||
| 1996 | $62.70M | +1922.6% | +$59.60M | ||
| 1995 | $3.10M | — | — |
In 2026, McKesson (MCK) buyback spend totalled $4.75B – surged 51.0% year-over-year.
McKesson buyback spend compound annual growth for the 2021–2026 (5 years) window is +45.0%, sustaining 2 straight years of year-over-year growth.
The dataset's maximum buyback spend sits at $4.75B (2026); the minimum reading of $0 dates to 1998.
Within Healthcare, McKesson (MCK) ranks 4th among 8 peers we track. The peer median for buyback spend is $2.75B.
McKesson Buyback Spend 2026: $4.75B
McKesson buyback spend in 2026 was $4.75B, surged 51.0% from 2025. This figure represents the highest annual value in the available history.
McKesson Buyback Spend 2025: $3.15B
McKesson buyback spend in 2025 was $3.15B, edged up 4.0% from 2024.
McKesson Buyback Spend 2024: $3.02B
McKesson buyback spend in 2024 was $3.02B, declined 16.8% below 2023.
McKesson Buyback Spend 2023: $3.64B
McKesson buyback spend in 2023 was $3.64B, edged up 3.5% from 2022.
McKesson Buyback Spend 2022: $3.52B
McKesson buyback spend in 2022 was $3.52B.
See more financial history for McKesson (MCK).
Sector peers by buyback spend
Companies in the same sector as McKesson, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group (UNH) | $5.54B | Healthcare |
| Merck & Co. (MRK) | $5.08B | Healthcare |
| Eli Lilly (LLY) | $4.11B | Healthcare |
| Novo Nordisk (NVO) | $1.39B | Healthcare |
| AbbVie (ABBV) | $980.00M | Healthcare |
| AstraZeneca (AZN) | $719.66M | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: N/A.
Capital allocation mix
How McKesson splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $5.55B (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from McKesson's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does McKesson buy back its own stock?
Yes, McKesson (MCK) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does McKesson spend on share buybacks?
Trailing twelve months (TTM) buyback spend is about $4.51B (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is McKesson's buyback yield?
TTM buyback yield is about 4.27% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is McKesson's shareholder yield?
Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 4.27% combined (TTM-based where available).
Is McKesson diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has McKesson's share count changed?
Diluted weighted average shares changed by about -22.7% over roughly five fiscal years (annual income statement data).
What is McKesson's buyback spend?
Latest reported buyback spend for McKesson (MCK) is $4.51B (period ending March 31, 2026).
How has McKesson buyback spend changed year-over-year?
McKesson (MCK) buyback spend changed +51.0% year-over-year on the latest annual filing.
What is the long-term growth rate of McKesson buyback spend?
McKesson (MCK) buyback spend compound annual growth rate is +45.0% over the most recent 5 years available.
When did McKesson buyback spend hit its highest annual value?
McKesson buyback spend reached its highest annual value of $4.75B in 2026.
What was McKesson buyback spend in 2025?
McKesson (MCK) buyback spend in 2025 was $3.15B.
What was McKesson buyback spend in 2026?
McKesson (MCK) buyback spend in 2026 was $4.75B.
Explore more
MCK Overview
Company profile, financial tools, and key metrics
MCK Revenue Counter
Earns $12,793 every second. See per minute, hour, and day.
MCK Earnings Counter
Earns $151.00 per second net profit. See per minute, hour, and day.
MCK Economic Scale
Exceeds South Africa's GDP. Compare with world economies.
MCK What If Invested
What if you had invested $1,000? See historical returns from any date.
MCK How It Makes Money
Discover visual breakdown of $403.43B in revenue — where it comes from and where it goes.
MCK Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MCK Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MCK Daily Price Character
Steady · 51.5% historical win rate (green days). Streaks & record days.
MCK Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
MCK Dividend Profile
Yield: 0.42%. Safety: 8/8. See full history.
MCK Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MCK Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
MCK Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).
MCK Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.